最近看到了一則新聞

新聞標題：誆治椎間盤突出…手戴套抹油「百人排隊花錢被插肛5分鐘」　他又痛又羞怒提告

新聞連結：留言處

點進去看第一段我就受不了。

記者唐詠絮、白珈陽／台中報導

台中西屯開設國術損傷整復館的羅姓父子，以食指戴套抹潤滑油插入患者肛門，聲稱1次
只要5分鐘便可以改善椎間盤突出及坐骨神經症狀，1次要價1200元，竟然有超過百名的患
者爭相排隊前往治療，其中1名患者被插入治療後，回到家覺得「還是超痛的」一氣之下
到台中第六警分局報警，整個案情才大曝光。

要跟大家說，這樣的手法是存在台灣也是有臨床有治療師在執行。但是標榜五分鐘喬尾椎就能改善椎間盤突出及神經症狀，是非常危險的行為。

今天不是要戰國術館，但是在沒有經過診斷與評估前，就進行治療根本亂槍打鳥，一個腰痛的原因可能來自於腰椎、臀部或骨盆薦椎都有可能，甚至更遠端的問題都有可能，而且治療方式也不只有徒手治療，大部分的人有如此問題都需要搭配運動治療甚至是針劑治療。

在沒有鑑別說，到底是哪邊的問題引起腰痛，就直接收費給別人督下去，實在是傷荷包又沒有效果，看到這邊我就要開始來介紹尾椎的部分了。

如果懶得看的話先說結論。

症狀：久坐或久站都會在尾椎處產生疼痛

首先尾椎痛有兩種人會比較容易得到

胖子
女人（比男性高五倍）

尾椎會痛有主要幾個原因。

1.外力導致受傷 例如：出車禍或摔傷。
2.薦喀關節與骨盆問題
3.退化性關節炎
4.薦椎尾骨關節活動度過大或過小
5.婦科問題
6.泌尿道問題
7.神經轉移痛

再來讓我們了解一下尾椎（coccyx）一詞的來源，是源自於希臘古文 kokkyx ("cuckoo")。
由於杜鵑喙（beak of cuckoo）形狀像尾椎，所以就變成coccyx。

尾椎結構上會透過周圍的肌肉與韌帶支撐，包括前側的提肛肌、薦尾韌帶，從前到後的外側邊緣會有尾骨肌、骶棘韌帶和 薦椎結節韌帶還有臀大肌的纖維，向下有髂骨尾骨肌的肌腱。透過這些組織可以協助穩定骨盆與腸道自主控制（肛門拉屎功能）。

有個好消息可以跟大家說，有九成以上尾椎痛的人可以藉由保守治療來改善症狀，只有不到一成的病患需要進一步的手術治療。

保守治療的方法包括
1.骨盆帶護具
2.坐姿訓練
3.冷熱療
4.電療
5.骨盆帶復健
6.整脊技術
7.針劑治療

但是在這些治療前都需要有醫療診斷，確定問題的來源，在進行治療。

而如果有尾椎痛的病人，建議去骨科或復健科找醫師評估，如果評估與婦科或泌尿道問題也會轉介給婦產科或泌尿科醫師，而治療的部分就需經過評估後，由醫師或治療師等專業人士進行治療。

文獻來源：Lirette, L. S., Chaiban, G., Tolba, R., & Eissa, H. (2014). Coccydynia: an overview of the anatomy, etiology, and treatment of coccyx pain. The Ochsner journal, 14(1), 84–87.

「Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China(2020/02/07)+中文摘要轉譯」


➥中文摘要轉譯：
截至2/4日，北京報告13例，大多為年輕健康人。症狀輕微且無人死亡。與過去報導一致，健康人感染後預後較佳。
註：初期流行病學易有偏誤，不可推估大流行時狀況。(財團法人國家衛生研究院-郭書辰醫師整理)


➥In December 2019, cases of pneumonia appeared in Wuhan, China. The etiology of these infections was a novel coronavirus (2019-nCoV),1,2 possibly connected to zoonotic or environmental exposure from the seafood market in Wuhan. Human-to-human transmission has accounted for most of the infections, including among health care workers.3,4 The virus has spread to different parts of China and at least 26 other countries.1 A high number of men have been infected, and the reported mortality rate has been approximately 2%, which is lower than that reported from other coronavirus epidemics including severe acute respiratory syndrome (SARS; mortality rate, >40% in patients aged >60 years)5 and Middle East respiratory syndrome (MERS; mortality rate, 30%).6 However, little is known about the clinical manifestations of 2019-nCoV in healthy populations or cases outside Wuhan. We report early clinical features of 13 patients with confirmed 2019-nCoV infection admitted to hospitals in Beijing.


「Methods」
Data were obtained from 3 hospitals in Beijing, China (Beijing Tsinghua Changgung Hospital, School of Medicine, Tsinghua University [8 patients], Beijing Anzhen Hospital, Capital Medical University [4 patients], and College of Respiratory and Critical Care Medicine, Chinese PLA General Hospital [1 patient]). Patients were hospitalized from January 16, 2020, to January 29, 2020, with final follow-up for this report on February 4, 2020. Patients with possible 2019-nCoV were admitted and quarantined, and throat swab samples were collected and sent to the Chinese Center for Disease Control and Prevention for detection of 2019-nCoV using a quantitative polymerase chain reaction assay.3 Chest radiography or computed tomography was performed. Data were obtained as part of standard care. Patients were transferred to a specialized hospital after diagnosis. This study was approved by the ethics commissions of the 3 hospitals, with a waiver of informed consent.


「Results」
The median age of the patients was 34 years (25th-75th percentile, 34-48 years); 2 patients were children (aged 2 years and 15 years), and 10 (77%) were male. Twelve patients either visited Wuhan, including a family (parents and son), or had family members (grandparents of the 2-year-old child) who visited Wuhan after the onset of the 2019-nCoV epidemic (mean stay, 2.5 days). One patient did not have any known contact with Wuhan.


Twelve patients reported fever (mean, 1.6 days) before hospitalization. Symptoms included cough (46.3%), upper airway congestion (61.5%), myalgia (23.1%), and headache (23.1%) (Table). No patient required respiratory support before being transferred to the specialty hospital after a mean of 2 days. The youngest patient (aged 2 years) had intermittent fever for 1 week and persistent cough for 13 days before 2019-nCoV diagnosis. Levels of inflammatory markers such as C-reactive protein were elevated, and numbers of lymphocytes were marginally elevated (Table).


Four patients had chest radiographs and 9 had computed tomography. Five images did not demonstrate any consolidation or scarring. One chest radiograph demonstrated scattered opacities in the left lower lung; in 6 patients, ground glass opacity was observed in the right or both lungs (Figure). As of February 4, 2020, all the patients recovered, but 12 were still being quarantined in the hospital.


➥Author: De Chang, Minggui Lin, Lai Wei, et al.

➥Link: (JAMA) https://jamanetwork.com/journals/jama/fullarticle/2761043


衛生福利部
疾病管制署 - 1922防疫達人
疾病管制署
國家衛生研究院-論壇
#2019COVID19Academic

「Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China(2020/02/07)+中文摘要轉譯」


➥中文摘要轉譯：
截至2/4日，北京報告13例，大多為年輕健康人。症狀輕微且無人死亡。與過去報導一致，健康人感染後預後較佳。
註：初期流行病學易有偏誤，不可推估大流行時狀況。(財團法人國家衛生研究院-郭書辰醫師整理)


➥In December 2019, cases of pneumonia appeared in Wuhan, China. The etiology of these infections was a novel coronavirus (2019-nCoV),1,2 possibly connected to zoonotic or environmental exposure from the seafood market in Wuhan. Human-to-human transmission has accounted for most of the infections, including among health care workers.3,4 The virus has spread to different parts of China and at least 26 other countries.1 A high number of men have been infected, and the reported mortality rate has been approximately 2%, which is lower than that reported from other coronavirus epidemics including severe acute respiratory syndrome (SARS; mortality rate, >40% in patients aged >60 years)5 and Middle East respiratory syndrome (MERS; mortality rate, 30%).6 However, little is known about the clinical manifestations of 2019-nCoV in healthy populations or cases outside Wuhan. We report early clinical features of 13 patients with confirmed 2019-nCoV infection admitted to hospitals in Beijing.


「Methods」
Data were obtained from 3 hospitals in Beijing, China (Beijing Tsinghua Changgung Hospital, School of Medicine, Tsinghua University [8 patients], Beijing Anzhen Hospital, Capital Medical University [4 patients], and College of Respiratory and Critical Care Medicine, Chinese PLA General Hospital [1 patient]). Patients were hospitalized from January 16, 2020, to January 29, 2020, with final follow-up for this report on February 4, 2020. Patients with possible 2019-nCoV were admitted and quarantined, and throat swab samples were collected and sent to the Chinese Center for Disease Control and Prevention for detection of 2019-nCoV using a quantitative polymerase chain reaction assay.3 Chest radiography or computed tomography was performed. Data were obtained as part of standard care. Patients were transferred to a specialized hospital after diagnosis. This study was approved by the ethics commissions of the 3 hospitals, with a waiver of informed consent.


「Results」
The median age of the patients was 34 years (25th-75th percentile, 34-48 years); 2 patients were children (aged 2 years and 15 years), and 10 (77%) were male. Twelve patients either visited Wuhan, including a family (parents and son), or had family members (grandparents of the 2-year-old child) who visited Wuhan after the onset of the 2019-nCoV epidemic (mean stay, 2.5 days). One patient did not have any known contact with Wuhan.


Twelve patients reported fever (mean, 1.6 days) before hospitalization. Symptoms included cough (46.3%), upper airway congestion (61.5%), myalgia (23.1%), and headache (23.1%) (Table). No patient required respiratory support before being transferred to the specialty hospital after a mean of 2 days. The youngest patient (aged 2 years) had intermittent fever for 1 week and persistent cough for 13 days before 2019-nCoV diagnosis. Levels of inflammatory markers such as C-reactive protein were elevated, and numbers of lymphocytes were marginally elevated (Table).


Four patients had chest radiographs and 9 had computed tomography. Five images did not demonstrate any consolidation or scarring. One chest radiograph demonstrated scattered opacities in the left lower lung; in 6 patients, ground glass opacity was observed in the right or both lungs (Figure). As of February 4, 2020, all the patients recovered, but 12 were still being quarantined in the hospital.


➥Author: De Chang, Minggui Lin, Lai Wei, et al.

➥Link: (JAMA) https://jamanetwork.com/journals/jama/fullarticle/2761043


衛生福利部
疾病管制署 - 1922防疫達人
疾病管制署
國家衛生研究院-論壇
#2019COVID19Academic

今日は、新型コロナウイルス緊急対策動画です。

不要不急の外出は避けるようにと東京都では、外出自粛が宣言されていますが、とうとう新型コロナウイルスの蔓延の危機がすぐそこまで迫ってきました。

本当に恐ろしいです…。泣

ひとつひとつの行動を気を付けることはもちろんだけど、それ以外にできることといえば、やっぱり免疫力をあげることを意識することなのではないでしょうか？

私たち人間にはちゃんと、外敵を体の中に入れないようにバリアを張る力があります。でもこのバリアを張る力には、残念ながら個人差があるんです。

これまでにも免疫力をあげる系の動画はたくさん作ってきましたが、
今だからこそもう一度基礎の基礎をおさらいしてみたいと思います。

＃新型コロナウイルス
＃インフルエンザ
＃免疫力を高める

-----------

腸内環境を整える方法や発酵食品の活用方法など、腸や菌にまつわる情報を毎週配信中！

このチャンネルは、微生物のおかげで、おデブ・吐き気・イライラ・ネガティブから救われた元おデブのアラフォー腸活研究家である長谷川ろみが、アクティブな100歳を目指して、「菌のこと」「発酵のこと」「腸のこと」を日々研究するチャンネルです。

下記のURLより「共同研究員さん（チャンネル登録者さん）」募集中！

▼チャンネル登録はこちらから
https://www.youtube.com/channel/UCyya...

▼活動概要
・元おデブ-20kg/アラフォー
・腸活メディア「腸内革命」編集長 & 講師
・発酵ライフ推進協会 通信校 校長 & 発酵ライフプロフェッショナル
・特定非営利活動法人 日本レホルム連盟 講師 & 腸内環境アドバイザー
・東京商工会議所認定　健康経営アドバイザー
・著書「発酵菌早わかりマニュアル」
・2019/6～腸活youtuber始めました！

▼メディア
腸活WEBメディア「腸内革命」
https://www.chounaikankyou.club/

▼オンラインショップ
「腸内革命」限定ショップ
https://chokatsu.theshop.jp/

▼発酵資格通信校プロデュース
発酵ライフアンバサダー養成講座
https://hakkolife.com/page-seminar_de...

▼Twitter/Instagramもやっているのでよかったらみてみてください！
Twitter： https://twitter.com/haseromi
Instagram： https://www.instagram.com/hasegawaromi/
LINE@：bea9895u

↓お仕事の依頼は下記メールアドレスまでお願いします↓
hasegawaromi63@gmail.com

▼関連動画
新型コロナウイルス対策　食べて免疫力を高めておこう
https://youtu.be/RrPsk3nuo60

風邪やインフルエンザの予防に！免疫力をUPする食べ物10選！
https://youtu.be/XbHbxnIPT08

【新型コロナウイルス】免疫力を高める３つの体質６つの食べ物
https://youtu.be/dnNrmb7zGKQ

免疫力アップに役立つ食品１０選！免疫力を高め風邪をひかない身体に！オススメの食べ方は？知ってよかった雑学
https://youtu.be/IS6oIYinkkk

免疫力を高める凄すぎる食べ物10選！風邪をひかない身体を作る食べ物とは？インフルエンザには・・知ってよかった健康雑学
https://youtu.be/1gvkPd8G_CM

▼参考：研究結果&論文等
Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes.
https://www.ncbi.nlm.nih.gov/pubmed/1...

Effects of vitamin D supplementation on salivary immune responses during Marine Corps basic training
https://onlinelibrary.wiley.com/doi/a...

免疫応答におけるビタミンCの生理学的役割
https://www.jstage.jst.go.jp/article/...

ビタミンAとβ-カロテンによる疾病の予防と治療
https://www.jstage.jst.go.jp/article/...

※この動画は、診断・治療または医療アドバイスを提供しているわけではありません。あくまで情報提供のみを目的としています。
※診断や治療に関する医療については、医師または医療専門家に相談してください。この動画は医療専門家からのアドバイスに代わるものでもありません。

参考文献
https://ci.nii.ac.jp/naid/130006943260

ニキビの発症メカニズム，治療，予防
The Etiology, Treatment, and Prevention of Acne


Gussan 　　（グッサン）

★化粧品成分上級スペシャリスト
.
★元ヘアメイクアーティスト★
.
【WORKS】
木村文乃 、AAA、M-flo RISA、はるな愛、他アーティスト、モデル、アナウンサー、タレント、芸人多数。
CM : NIKE、ポッカ、ハウス食品、花王、大正製薬、etc.
VP : TOYOTA、JR、三井不動産、富士急ハイランド、etc.
雑誌 : 講談社、角川書店、双葉社、扶桑社、宝島社、etc.
その他 : 東京コレクション、映画、ドラマ、TV多数。
.
【経歴】
六本木のヘアメイクサロンで店長を務め、売り上げNo. 1を取り続ける。
その後エイベックス、フジテレビ系列の仕事を主として活動するヘアメイク事務所に所属し、
TV、CM、アーティスト、ドラマ、雑誌、映画、コレクション、ファッションショー、VPなど数々の仕事をこなす。
その後フリーのヘアメイクとして活動し、会社を設立。
健康と美容をテーマに、食品原料や化粧品原料、美容業などで活動する。

□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■□■

《メッセージ》

【現場】【流通】【原料】【製造】【成分】
これら全てに携わった人はほとんど見当たらず、
そういった様々な側面から見た知識、経験を使って、
付加価値の高い有益な情報を提供する事により、
広告などにも騙されないず、理にかなった
【本質的に良いもの】を見つけることが出来、
1人でも多くの方が美容や食などに興味を持ち、
綺麗で健康になって頂くのが
僕の役目であると思っています！！

基本、エビデンス（化学的証明）を元に判断を下すのがベストであると考えます。




💎一般の方が知らない情報も💎

Instagram

https://www.instagram.com/ftsota



Twitter

http://twitter.com/gussan88888